ArticleNeuro-oncology2024

EGFR amplification and EGFRvIII predict and participate in TAT-Cx43266-283 antitumor response in preclinical glioblastoma models.

Andrea Álvarez-Vázquez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.